Schedule a Meeting
Download Brochure
Table of Content
May 2025
The global curcumin market size was estimated at USD 98.92 million in 2024 and is projected to grow from USD 110.59 million in 2025 to USD 301.79 million by 2034, expanding at a CAGR of 11.8% from 2025 to 2034. The increased prevalence of several diseased conditions associated with cardiovascular, chronic, hepatocellular, and neurological disorders and the emerging need to prevent and treat them effectively drives the growth of the market.
Curcumin refers to a phenolic phytochemical extracted from the Curcuma longa rhizome that exhibits several biological activities and drug-like properties, being natural compounds. Due to this, it is ideally used to develop compounds and discover drugs for treating chronic illnesses. The curcumin market is experiencing significant growth due to the numerous pharmacological benefits of curcumin, including its antimutagenic, anti-inflammatory, antioxidant, and antimicrobial properties. Moreover, curcumin provides immunoregulatory, chemo preventive, and chemotherapeutic properties.
According to the National Turmeric Board (NTB), India dominates the global turmeric industry by having major varieties with geographical indication tags, such as Erode Turmeric (Tamil Nadu), Kandhamal Haldi (Odisha), and Lakadong Turmeric (Meghalaya), that are known for high curcumin content. According to clinical trial studies conducted by the National Cancer Institute (NCI), the curcumin-containing products showcase anticancer and anti-oral mucositis effects in the paediatric population.
The biomarker studies allow us to test the applications of curcumin-containing products as an adjunctive therapy. Research studies suggest a possible antitumor effect of curcumin-containing products. Patients with metastatic adenoid cystic carcinoma (ACC) can undergo research involving iMAtinib and curcumin-containing products. It is possible to explore the tolerability, efficacy, and feasibility of DOCEtaxel plus are the products that contains in the curcumin which helps in the treatment of cancer.
The increased cost-effectiveness of certain antimicrobial medications and the increased prevalence of antimicrobial drug resistance are the emerging challenges in the curcumin market. According to researchers, this drug resistance can result in a global cause of death. There is an urgent need for improvements and modifications in natural antimicrobial agents to address these issues in chemically synthesized medicines.
North America dominated the curcumin market in 2024.
The presence of the leading market players such as SabinsaCorp uplifts the regional market’s growth significantly. SabinsaCorp launched several products, including LivLonga, which is a combination of three natural ingredients such as Curcumin C3 Complex®, Livinol® and BioPerine®. Moreover, SabinsaCorp introduced Curcumin C3 Reduct, which was the first product approved by the European Food Safety Authority (EFSA) and is renowned as a novel food-active metabolite of Curcuminoids that is standardized for a minimum of 95% Tetrahydrocurcuminoids.
The Curcumin Market Hits the Growth of The United States
According to one of the research studies funded by the UF/IFAS Support for Emerging Enterprise Development Integration Teams (SEEDIT) program and the U.S. Department of Agriculture Specialty Crop Block Grant, most turmeric produced in the U.S. is imported. This research project was conducted on the production of ginger, turmeric, and galangal in Florida, which is a state in the Southeast region of the U.S. in North America. This research study was administered through the Florida Department of Agriculture and Consumer Services (FDACS). The importers and retailers involved in turmeric produce sell turmeric to retailers, food service, wholesalers, and food or beverage manufacturers. The integrated global companies contribute as importers in the production, packaging, and distribution of turmeric.
Asia Pacific expects the fastest rate of growth in the curcumin market during the predicted timeframe.
The presence of prominent companies like BioMaxLifesciences Ltd. which is primarily located in India (Hyderabad, Telangana) upholds the regional market’s statistics. BioMaxLifesciences Ltd. introduced various products and services, including weight management medicines, antioxidant extracts, spray-dried vegetable powder, natural food colors, nutraceuticals, and oleoresins. BioMaxLifesciences Ltd. launched several nutraceuticals, such as lutein, lycopene, methyl sulphonyl methane, mono ammonium glycyrrginate, and Soy Isoflavone. Moreover, this company has also introduced natural food colors related to paprika, red beet root, and safflower yellow.
The Leading Steps of China towards the Expansion of the Curcumin Market
Top Curcumin Suppliers in China
Growth Trajectory of Curcumin Market in India
The Union Minister for Commerce and Industry announced the launch of the National Turmeric Board (NTB), which includes the representatives of the Ministry of AYUSH, Department of Agriculture & Farmers Welfare, Department of Pharmaceuticals, and the Department of Commerce as prominent members. India accounts for 70% of global production and 62% of global trade for turmeric. India holds the first position as the largest producer, consumer, and exporter of turmeric. Maharashtra, Telangana, Karnataka and Tamil Nadu are the largest turmeric-producing states.
Europe is seen to grow at a notable rate in the curcumin market during the forecast period. Vitafoods Europe 2025 is the world's leading nutraceutical trade show organized in Spain in May 2025 in which several companies and global importers of turmeric from Europe showcased their product portfolios. Husarich GmbH is one of the leading companies in Europe associated with certifications and collaborations such as Fachverband der Gewürzindustrie e.V. (Association of the German Spice Industry), Bonn and foodactive e. V (c/o Süderelbe AG), Hamburg. Husarich GmbH launched several products related to spices and seeds, herbs, and onion and garlic.
The presence of the leading importers of organic turmeric from Europe such as Wacker Chemie AG (Germany), Dr. Behr GmbH (Germany), and Tradin Organic (Netherlands) accelerates the regional market’s expansion across Europe. Moreover, the leading exporters of curcumin to Europe include Ayusri Health Products (India), Vitabay (Germany), Bio Import Europa (Germany), etc.
Versatile Curcumin Product Portfolio of Germany
In May 2025, Sabinsa Europe GmbH announced it would introduce LactoBeet and highlight curcumin C3 reduction at VitaFoods Europe 2025. The company also planned to present its other products such as Cirpusins, Saberry, Nigellin, Shagandha, and Sabeet at this event. In April 2025, Sabinsa Europe GmbH reported featuring its product portfolio of well-researched and category-leading ingredients at SupplySide Connect New Jersey.
The powder segment dominated the curcumin market in 2024.
The powder forms are ideal because each dose contains a different amount of active drug. The powder forms are most suitable due to their ease of administration for infants and young children who are unable to swallow tablets or capsules. The drugs present in the powder form tend to be most stable as a solid. The drugs can be made in several different dosage formulations, like bulk powders, powders for inhalation, powders for reconstitution, etc.
The liquid segment is expected to witness the fastest rate of growth in the curcumin market during the predicted timeframe.
The liquid dosage forms show faster adsorption than solid dosage forms. The liquids show easier of swallowing than tablets and capsules, which makes them more suitable options. Drugs with larger doses can be easily administered in liquid dosage forms.
The organic curcumin segment dominated the curcumin market in 2024.
The organic curcumin reduces inflammation, improves memory, and fights against free radicals. The growth of organic curcumin is driven by its contribution to lowering the risk of heart disease, reducing depression symptoms, and preventing cancer. It also reduces the risk of diabetes and cardiovascular diseases, which makes them ideal medicinal options for the global population.
The conventional curcumin segment is observed to be the fastest growing in the curcumin market during the forecast period.
The conventional curcumin has achieved an expansive reach due to its potential to prevent skin disease and diabetic cataracts. It is ideally applicable in treating autoimmune diseases and serves beneficial effects in neuroprotection. It plays a major role in cell cycle arrest, apoptosis, and autophagy.
The antioxidant segment dominated the curcumin market in 2024.
Curcumin plays a major role as an antioxidant which prevents free radical damage in the human body. The antioxidant properties of curcumin and its water-and-fat-soluble extracts serve the same as those of vitamin C and vitamin E. Curcumin is referred to as a chain-breaking antioxidant, like vitamin E.
The anti-inflammation segment expects to grow at the fastest rate in the curcumin market in the upcoming years.
The anti-inflammatory properties of curcumin regulate target tissues reactions to inflammatory mediators. The anti-inflammatory role of curcumin prevents and treats several conditions such as Parkinson’s disease, Alzheimer’s disease, epilepsy, sclerosis, cerebral injury, metabolic disorders, cancer, cardiovascular disease, allergies, arthritis, etc.
The herbal & medicinal products segment dominated the curcumin market in 2024.
The cost-effectiveness and availability of herbal & medicinal products drive their remarkable growth among the global population. They elicit reduced risk of side effects and are sustainable and eco-friendly in nature. They are strong immune boosters and serve people with enhanced self-healing experiences.
The cosmetics segment is anticipated to grow at a rapid rate in the curcumin market during the forecast period.
Cosmetics provide people, especially women, with improved self-confidence, skin protection, and improved looks. People feel and look younger and present themselves with creative expressions. People can experience enhanced appearance, relaxation, and stress relief using cosmetics.
Konark Herbals & Healthcare
DolCas Biotech
By Form
By Nature
By Application
By End Use
By Region
May 2025
May 2025
May 2025
May 2025
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published40+
Consulting Projects Per Year25+
Analysts